How can Cerus improve the shelf life of its INTERCEPT Blood System for platelets?

Introduction

To improve the shelf life of Cerus' INTERCEPT Blood System for platelets, we need to conduct a comprehensive analysis of the product, its users, and the broader ecosystem. I'll approach this challenge by examining key stakeholders, identifying pain points, generating innovative solutions, and proposing a strategic implementation plan. Let's dive in.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the current shelf life of the INTERCEPT Blood System for platelets. Could you provide more information on the current shelf life and what specific improvements we're targeting?

Why it matters: This will help us set a baseline and determine the scale of improvement needed. Expected answer: Current shelf life is 5-7 days, aiming for 10-14 days. Impact on approach: A significant increase would require more radical solutions, while a modest increase might focus on incremental improvements.

• Considering user behavior, I'm curious about the primary use cases and settings where the INTERCEPT Blood System is deployed. Are we primarily focusing on hospital blood banks, mobile blood drives, or other specific environments?

Why it matters: Different settings may have unique constraints or requirements that could impact our solution. Expected answer: Primarily used in hospital blood banks and regional blood centers. Impact on approach: Would tailor solutions to the specific needs and constraints of these environments.

• Regarding product lifecycle and company alignment, where does the INTERCEPT Blood System stand in terms of market adoption, and what are the key business objectives driving this improvement initiative?

Why it matters: Helps us understand if we should focus on expanding market share or improving existing customer satisfaction. Expected answer: Established product with significant market share, looking to maintain competitive edge and increase value for existing customers. Impact on approach: Would prioritize solutions that enhance customer loyalty and differentiate from competitors.

• Considering external factors, how has the regulatory landscape evolved recently, and are there any upcoming changes that might impact blood product storage and handling?

Why it matters: Regulatory compliance is crucial in medical products and could significantly influence our solution space. Expected answer: Increasing focus on extended storage times and reducing waste in blood product management. Impact on approach: Would ensure all solutions align with current and anticipated regulatory requirements.